Tirzepatide is primarily researched as a dual GIP and GLP-1 receptor agonist, with studies focused on incretin signalling, metabolic regulation, and energy balance.
Tirzepatide is a synthetic peptide-based dual agonist designed to interact with the GLP-1 and GIP receptors. It is extensively studied in research involving incretin signalling, glucose metabolism, appetite-related pathways, endocrine responses, and energy regulation. Tirzepatide provides a well-defined molecular tool for controlled investigations of coordinated GLP-1/GIP receptor activity.
This product is prepared for laboratory research use only and may not be used for other purposes. All compounds are supplied in sealed research vials.
$9 Flat-Rate Shipping Canada-Wide. Free Shipping On Orders Over $300. 
